Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades22,458
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Share Price Information for Astrazeneca (AZN)
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
LONDON BRIEFING: WH Smith to sell UK High Street business
(Alliance News) - London stocks are called to open higher on Friday, as gold reaches new record highs and investors begin to digest an upwardly revise...
AstraZeneca highlights new Tagrisso data in lung cancer trials
(Alliance News) - AstraZeneca PLC on Tuesday reported positive new study results for its lung cancer drug Tagrisso, strengthening its position as a "b...
Angle hails successful completion of Eisai contract; approval by Astra
(Alliance News) - Angle PLC on Friday said the results of an Eisai Co Ltd pilot study supported the capability of the Parsortix system for real-time a...
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
AstraZeneca is largest drugmaker in China, has invested billions *
AstraZeneca to invest USD2.5 billion in new Beijing strategic centre
(Alliance News) - AstraZeneca PLC on Friday said it will establish a new global strategic research & development centre in Beijing.
AstraZeneca spending $2.5bn on new R&D centre, biotech deals in China
(Sharecast News) - Pharma giant AstraZeneca announced on Friday that it is investing $2.5bn in a new global R&D centre in China, along with major rese...
AstraZeneca investing $2.5 bln in China as drugmaker seeks to recover from scandals
AstraZeneca commits further to China with $2.5 bln investment *
IN BRIEF: Hutchmed highlights positive lung cancer test results
Hutchmed China Ltd - Hong Kong-based biopharmaceutical firm - Results from the Savannah phase 2 trial showed savolitinib plus Tagrisso achieved a clin...
Follow the stocks
